The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons.
João Paulo Capela, Silvana Da Costa Araújo, Vera Marisa Costa, Karsten Ruscher, Eduarda Fernandes, Maria de Lourdes Bastos, Ulrich Dirnagl, Andreas Meisel, Félix Carvalho
Neurotoxicology January 2013 DOI: 10.1016/j.neuro.2012.09.005 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | In vitro experimental study Peer reviewed |
|---|---|
| Population | Primary hippocampal neuronal cultures from Wistar rat embryos (E-17 to E-19) |
| Interventions | MDMA DOI |
| Dose | MDMA 100-800 μM; DOI 10-100 μM |
| Duration | 24 or 48 h exposure |
| Measures | lactate dehydrogenase (LDH) release, tetrazolium-based (MTT) assay, caspase-8 activity, caspase-3 activity, Western blot for apoptosis inducing factor (AIF), cytochrome c |
| Key findings | MDMA and DOI both produced concentration- and time-dependent death of cultured rat hippocampal neurons, accompanied by caspase-8 and caspase-3 activation and mitochondrial changes, with DOI causing greater caspase activation than MDMA at equally toxic concentrations. An antibody against the 5-HT(2A) receptor greatly attenuated death after 48-hour exposure, indicating that toxicity depends at least in part on 5-HT(2A) receptor stimulation. |
Abstract
3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") and 2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI) are hallucinogenic amphetamines with addictive properties. The hippocampus is involved in learning and memory and seems particularly vulnerable to amphetamine's neurotoxicity. We evaluated the neurotoxicity of DOI and MDMA in primary neuronal cultures of hippocampus obtained from Wistar rat embryos (E-17 to E-19). Mature neurons after 10 days in culture were exposed for 24 or 48 h either to MDMA (100-800 μM) or DOI (10-100 μM). Both the lactate dehydrogenase (LDH) release and the tetrazolium-based (MTT) assays revealed a concentration- and time-dependent neuronal death and mitochondrial dysfunction after exposure to both drugs. Both drugs promoted a significant increase in caspase-8 and caspase-3 activities. At concentrations that produced similar levels of neuronal death, DOI promoted a higher increase in the activity of both caspases than MDMA. In the mitochondrial fraction of neurons exposed 24h to DOI or MDMA, we found a significant increase in the 67 kDa band of apoptosis inducing factor (AIF) by Western blot. Moreover, 24h exposure to DOI promoted an increase in cytochrome c in the cytoplasmatic fraction of neurons. Pre-treatment with an antibody raised against the 5-HT(2A)-receptor (an irreversible antagonist) greatly attenuated neuronal death promoted by 48 h exposure to DOI or MDMA. In conclusion, hallucinogenic amphetamines promoted programmed neuronal death involving both the mitochondria machinery and the extrinsic cell death key regulators. Death was dependent, at least in part, on the stimulation of the 5-HT(2A)-receptors.
Citations in the library
Cited by 11
- Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs Frontiers in Psychiatry August 18, 2017
- MDMA Increases Glutamate Release and Reduces Parvalbumin-Positive GABAergic Cells in the Dorsal Hippocampus of the Rat: Role of Cyclooxygenase Journal of Neuroimmune Pharmacology November 17, 2012
- A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA) Current Research in Toxicology May 27, 2022
- [Psychedelic and dissociative agents in psychiatry: challenges in the treatment]. Der Nervenarzt September 1, 2024
- Protective Effects of Atorvastatin and Rosuvastatin on 3,4-methylenedioxymethamphetamine (MDMA)-Induced Spatial Learning and Memory Impairment Research Square
and 6 more in the library
Cites 18
- Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings The Lancet October 1, 1998
- Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery Journal of Neuroscience June 15, 1999
- (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals Neuropsychobiology 2000
- Blockade of 5-HT2 Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment Neuropsychopharmacology May 11, 2011
- Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: Temporal, spatial, and cellular patterns The Journal of Comparative Neurology 2006
and 13 more in the library